OncoImmunology
Volume 1, 2012 - Issue 2
Open access
408
Views
4
CrossRef citations to date
0
Altmetric
Author's View
Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment
Alessandro Poggi Unit of Molecular Oncology and Angiogenesis; San Martino Hospital-National Institute for Cancer Research; University of Genoa; Genoa, ItalyCorrespondence[email protected] [email protected]
& Maria Raffaella Zocchi Division of Immunology; Transplants and Infectious Diseases; Scientific Institute San Raffaele; Milan, ItalyCorrespondence[email protected] [email protected]
Pages 214-216
|
Published online: 01 Mar 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.